$1.51
-0.03 (-1.95%)
Open$1.55
Previous Close$1.54
Day High$1.69
Day Low$1.51
52W High$48.81
52W Low$29.95
Volume—
Avg Volume421.0K
Market Cap94.02M
P/E Ratio39.45
EPS$0.99
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+2,899.3% upside
Current
$1.51
$1.51
Target
$45.29
$45.29
$33.37
$45.29 avg
$67.77
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 59.72M | 61.79M | 57.95M |
| Net Income | -17,457,928 | -16,293,891 | -13,275,510 |
| Profit Margin | -29.2% | -26.4% | -22.9% |
| EBITDA | -19,228,267 | -21,164,861 | -19,065,899 |
| Free Cash Flow | -18,637,383 | -17,592,445 | -15,576,212 |
| Rev Growth | -4.4% | +5.4% | +21.5% |
| Debt/Equity | 0.30 | 0.31 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |